Found: 7
Select item for more details and to access through your institution.
Alprazolam-ritonavir interaction: Implications for product labeling<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 67, n. 4, p. 335, doi. 10.1067/mcp.2000.105757
- By:
- Publication type:
- Article
Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 6, p. 661, doi. 10.1016/S0009-9236(98)90057-1
- By:
- Publication type:
- Article
Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 5, p. 553, doi. 10.1016/S0009-9236(98)90139-4
- By:
- Publication type:
- Article
Inhibition of triazolam clearance by macrolide antimicrobial agents: In vitro correlates and dynamic consequences<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 3, p. 278, doi. 10.1016/S0009-9236(98)90176-X
- By:
- Publication type:
- Article
Alzheimer’s disease treatment: Assessing caregiver preferences for mode of treatment delivery.
- Published in:
- Advances in Therapy, 2009, v. 26, n. 6, p. 627, doi. 10.1007/s12325-009-0034-5
- By:
- Publication type:
- Article
Short-Term Exposure to Low-Dose Ritonavir Impairs Clearance and Enhances Adverse Effects of Trazodone.
- Published in:
- Journal of Clinical Pharmacology, 2003, v. 43, n. 4, p. 414
- By:
- Publication type:
- Article
Relative Contribution of CYP3A to Amitriptyline Clearance in Humans: in Vitro and in Vivo Studies.
- Published in:
- Journal of Clinical Pharmacology, 2001, v. 41, n. 10, p. 1043, doi. 10.1177/009127000104101001
- By:
- Publication type:
- Article